March 20, 2017
3 min watch
Save

VIDEO: Nitric oxide-releasing gel shows efficacy in treating genital warts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

ORLANDO, Fla. — In a video perspective from the American Academy of Dermatology Annual Meeting, Stephen K. Tyring, MD, PhD, discusses late-breaking research he presented on SB206, a novel, nitric oxide-releasing topical gel for treating genital/perianal warts caused by human papillomavirus.

Tyring, clinical professor of dermatology at University of Texas Health Science Center at Houston, reported that SB206 (Novan) showed efficacy and appeared to be well tolerated in the phase 2 study, with SB206 12% once daily demonstrating significant difference compared with placebo.